[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576012":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":24,"responsibleParty":40,"collaborators":10,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":10,"eligibilityCriteria":47,"healthyVolunteers":44,"sex":48,"minAge":49,"maxAge":10,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Retrospective Group",null,"The retrospective phase will involve about 2850 patients of whom:\n\n* 500 with hypothyroidism;\n* 500 suffering from hyperthyroidism\u002Fthyrotoxicosis;\n* 1000 affe8ed with benign thyroid nodule;\n* 850 suffering from thyroid carcinoma.",{"label":13,"type":10,"description":14,"interventionNames":10},"Prospective Group","In the prospective phase, on the other hand, about 3000 patients will be sequentially enrolled, including:\n\n* 60\u002Fyear with hypothyroidism;\n* 60\u002Fyear suffering from hyperthyroidism\u002Fthyrotoxicosis;\n* 100\u002Fyear suffering from benign thyroid nodule;\n* 80\u002Fyear suffering from thyroid carcinoma.",[16],{"name":17,"affiliation":5,"role":18},"Uberto Pagotto, MD","PRINCIPAL_INVESTIGATOR",[20],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},"CONTACT","+390512144190","uberto.pagotto@unibo.it",[25],{"facility":5,"status":26,"city":27,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Bologna","40138","Italy","IT",{"type":32,"coordinates":33},"Point",[34,35],11.33875,44.49381,{"lat":35,"lon":34},[38,39],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},{"name":17,"role":21,"phone":10,"phoneExt":10,"email":10},{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100576012","evaluation-of-different-diagnostic-therapeutic-strategies-in-patients-with-thyroid-pathology-100576012",false,"NCT06779747","Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology","Inclusion Criteria:\n\n* Age older than 18 years at the time of diagnosis;\n* Patients with thyroid pathology (hypothyroidism, hyperthyroidism\u002Fthyrotoxicosis, benign thyroid nodule, and thyroid carcinoma) in whom the diagnosis was made in our Center or another Center from 01\u002F01\u002F1995 until the approval of this study (retrospective phase) or from the time of approval of this study to the next 10 years (prospective phase);\n* Obtaining informed consent.\n\nExclusion Criteria:\n\n* Follow up lasting less than 3 months;\n* Incomplete or missing clinical data that may affect the correct assessment of the patient.","ALL","18 Years",{"count":51,"type":52},5850,"ESTIMATED","20 Years","OBSERVATIONAL","Observational single-center prospective and retrospective, nonpharmacological, spontaneous cohort study.",[57,58,59,60],"Hypothyroidism","Hyperthyroidism\u002FThyrotoxicosis","Thyroid Nodule (Benign)","Thyroid Carcinoma","2025-01-13",{"date":63,"type":64},"2025-01-17","ACTUAL",{"date":66,"type":64},"2021-12-30",{"date":68,"type":52},"2041-12-30",{"name":5,"class":6},1]